Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: Prevalence estimates and risk factors

被引:45
作者
Johnson, Bjorn [1 ]
Richert, Torkel [1 ]
机构
[1] Malmo Univ, Dept Social Work, Malmo, Sweden
基金
瑞典研究理事会;
关键词
Methadone; Buprenorphine; Diversion; Illicit use; Opioid substitution treatment; NEEDLE EXCHANGE PROGRAMS; NEW-SOUTH-WALES; MAINTENANCE TREATMENT; DRUG-USERS; INJECTION; HEROIN; CLIENTS; DEATHS; ACCESS; ABUSE;
D O I
10.1016/j.drugpo.2014.10.003
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Diversion-patients who sell or share their medication-is a hotly debated but relatively unresearched phenomenon. We have investigated the prevalence of self-reported diversion of methadone and buprenorphine at OST programs in Sweden. We have also examined if demographic, treatment, and social factors can be associated with an increased risk of diversion. Methods: Structured interviews were conducted with 411 patients from eleven OST programs. A standardized questionnaire with 106 close- and five open-ended questions were used. 280 interviews were done on site, by the researchers, while 131 interviews were conducted by specially trained patients through privileged access interviewing. The data were analyzed through frequency- and averages-calculations, cross-tabulations, and logistic regression analysis. Results: In total, 24.1% (n = 99) of the patients reported diversion in the past month. 67.6% (n = 277) stated that they had diverted at some point. The peer interviews showed significantly higher levels of diversion (37.4% past month) compared with the researcher interviews (17.2%). Neither demographic factors, dosages, nor collection routines were associated with diversion. The likelihood of diversion was higher for patients on mono-buprenorphine (OR = 5.64) and buprenorphine-naloxone (OR = 2.10), than among methadone patients. Other factors which increased the likelihood of diversion were current illicit drug use (OR = 5.60), having had patients as a primary source of illicit methadone or buprenorphine prior to treatment (OR = 3.39), and mainly socializing with active drug users (OR = 2.12). Conclusion: Self-reported diversion was considerably higher than in previous studies. This is most likely due to the new methodological strategy we used, but may also partly be explained by low availability of OST in Sweden, leading to a high demand for the substances by heroin users outside treatment. Efforts to decrease diversion should primarily focus on psychosocial and lifestyle-changing interventions, and expanded access to treatment, rather than on control measures. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 50 条
[41]   Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians [J].
Johanson, Chris-Ellyn ;
Arfken, Cynthia L. ;
di Menza, Salvatore ;
Schuster, Charles Roberts .
DRUG AND ALCOHOL DEPENDENCE, 2012, 120 (1-3) :190-195
[42]   Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment [J].
Nielsen, Suzanne ;
Dietze, Paul ;
Lee, Nicole ;
Dunlop, Adrian ;
Taylor, David .
ADDICTION, 2007, 102 (04) :616-622
[43]   From methadone to buprenorphine: Changes during a 10 year period within a national opioid maintenance treatment programme [J].
Riksheim, Marianne ;
Gossop, Michael ;
Clausen, Thomas .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2014, 46 (03) :291-294
[44]   Retention rates in opioid maintenance treatment with methadone and buprenorphine - results from a 6-year observational study [J].
Soyka, Michael ;
Schmidt, Peggy ;
Wittchen, Hans-Ulrich ;
Buehringer, Gerhard .
HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2025, 27
[45]   Comparison of buprenorphine and methadone in the treatment of opioid dependence - Swiss multicentre study [J].
Uehlinger, C ;
Deglon, JJ ;
Livoti, S ;
Petitjean, S ;
Waldvogel, D ;
Ladewig, D .
EUROPEAN ADDICTION RESEARCH, 1998, 4 :13-18
[46]   Economic evaluation: A comparison of methadone versus buprenorphine for opiate substitution treatment [J].
Maas, Jim ;
Barton, Garry ;
Maskrey, Vivienne ;
Pinto, Hayley ;
Holland, Richard .
DRUG AND ALCOHOL DEPENDENCE, 2013, 133 (02) :494-501
[47]   Buprenorphine and Methadone Maintenance Treatment - Sexual Behaviour and Dysfunction Prevalence [J].
Giacomuzzi, S. M. ;
Khreis, A. ;
Riemer, Y. ;
Garber, K. ;
Ertl, M. .
LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (01) :13-13
[48]   Levamethadone as substitution treatment of opioid-dependent patients [J].
Mueller, E. A. ;
Kirch, W. .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (40) :2052-2056
[49]   Randomized clinical trial comparing buprenorphine/naloxone and methadone for the treatment of patients with failed back surgery syndrome and opioid addiction [J].
Neumann, Anne M. ;
Blondell, Richard D. ;
Hoopsick, Rachel A. ;
Homish, Gregory G. .
JOURNAL OF ADDICTIVE DISEASES, 2020, 38 (01) :33-41
[50]   Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone [J].
Kelty, Erin ;
Hulse, Gary .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 46 :54-60